Overview

* Corteva ( CTVA ) Q3 revenue grows 13%, beating analyst expectations

* Company raises full-year 2025 guidance due to strong YTD performance

* Corteva ( CTVA ) plans separation into two independent companies by 2026

Outlook

* Corteva ( CTVA ) raises full-year 2025 net sales guidance to $17.7 bln-$17.9 bln

* Operating EBITDA for 2025 expected between $3.8 bln and $3.9 bln

* Corteva ( CTVA ) expects 2025 operating EPS of $3.25 to $3.35

Result Drivers

* CROP PROTECTION DEMAND - Double-digit volume growth in new products and biologicals drove Crop Protection results

* SEED DEMAND - Demand for newest hybrids and varieties, strong operational execution, and growth in out-licensing boosted Seed results

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $2.61 $2.47

Revenue bln bln (15

Analysts

)

Q3 -$23

Adjusted

EPS

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 18 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the agricultural chemicals peer group is "buy"

* Wall Street's median 12-month price target for Corteva Inc ( CTVA ) is $79.00, about 21.4% above its November 3 closing price of $62.06

* The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 22 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)